A series of neutral trials on anticoagulation in embolic stroke of undetermined source (ESUS) has moved the needle scientifically but left physicians with questions about secondary prevention and the ...

Low-dose rivaroxaban failed to cut the high cardiovascular risk in this population in a large randomized trial, contrasting ...

Early on in the COVID-19 pandemic, patient presentations and autopsy reports made it abundantly clear that abnormal coagulation and multiorgan clotting were key signatures of this disease. Interim ...

In patients with device-detected atrial fibrillation and a prior stroke, oral anticoagulation increases bleeding without a clear reduction in stroke. This finding was presented by Prof. Paulus ...

USA: A multinational clinical trial published in the New England Journal of Medicine has reported that ultrasound ...

Anticoagulants are one of the most commonly prescribed medication classes, and the utilization of these agents is on the rise. Anticoagulants are prescribed for many indications, including prevention ...

Please provide your email address to receive an email when new articles are posted on . Among young patients with provoked venous thromboembolism, shorter duration of anticoagulation is noninferior to ...

Changes in the hemostatic system and chronic hemostatic activation are frequently observed in patients with cancer, even in the absence of venous thromboembolism (VTE). VTE is a leading cause of death ...

To the Editor: Douketis et al. (Aug. 27 issue) 1 report on the results of the Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive ...

Lead asset CAD-1005 being researched for prevention of life-threatening blood clots in patients with Heparin-induced Thrombocytopenia (HIT), ...

MADRID -- Stopping oral anticoagulation after successful ablation for atrial fibrillation (AF, Afib) improved outcomes for patients without documented recurrence, the randomized ALONE-AF trial showed.